Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
9UA:FRA
NervGen Pharma Corp
€3.30
-3.51%
(-0.12) 1D
Apr 24, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 9UA...
Open
€3.30
High
€3.30
Low
€3.30
Mkt. cap
315.71M
Avg. vol.
29.00
Volume
0.00
52-wk high
€5.00
52-wk low
€1.69
No. of employees
10
News stories
From sources across the web
About NervGen Pharma Corp
CEO-
Employees10
Founded2017
HeadquartersVancouver, British Columbia, Canada
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.15M
2.71M
4.44M
3.60M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.89M
3.76M
1.73M
2.80M
Operating expense
6.04M
6.47M
6.17M
6.40M
Total operating expenses
6.04M
6.47M
6.17M
6.40M
Operating income
-6.04M
-6.47M
-6.17M
-6.40M
Other non operating income
2.00M
-2.70M
1.98M
-20.24M
EBT including unusual items
-3.95M
-9.10M
-4.16M
-26.91M
EBT excluding unusual items
-3.95M
-9.10M
-4.16M
-26.91M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.95M
-9.10M
-4.16M
-26.91M
Net profit margin
-
-
-
-
Earnings per share
-0.06
-0.13
-0.06
-
Interest and investment income
107.76K
86.90K
77.07K
61.68K
Interest expense
-
-
-
-
Net interest expenses
107.76K
86.90K
77.07K
61.68K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.02M
-6.46M
-6.16M
-6.39M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more